sympatico: safety and efficacy of ibrutinib plus venetoclax for r/r mcl
Published 3 years ago • 88 plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
3:37
sympatico: ibrutinib combined with venetoclax in patients with r/r mcl
-
1:52
sympatico: primary analysis results of ibrutinib plus venetoclax for patients with r/r mcl
-
3:28
the sympatico trial: ibrutinib plus venetoclax in tp53-mutated mcl
-
1:39
the safety of venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (vipor) in r/r mcl
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
5:04
efficacy and safety of m-pola for r/r b-cell nhl
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
10:27
11.3 proteobacteria
-
3:51
sickle cell disease | moa animation
-
6:23
fc bridged cell-mediated cytotoxicity
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
4:02
elm-2: promising safety and efficacy of odronextamab in r/r dlbcl
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:30
final results of the aim study of ibrutinib and venetoclax in mantle cell lymphoma
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
2:00
obinutuzumab, ibrutinib, and venetoclax in high-risk cll: the cll2-give and cll13 trials
-
0:59
the safety and efficacy of etavopivat in scd
-
3:57
sympatico: is ibrutinib combined with venetoclax safe and effective in patients with r/r mcl?
-
4:45
safety and efficacy of obe-cel in r/r adult b-all: results of the pivotal felix study
-
1:43
updates on the use of bispecific antibodies in mcl & the need for more studies in this space
-
2:45
optimizing the combination of ibrutinib plus venetoclax in cll
-
0:44
clinical efficacy and safety of ct-p10 in patients with dlbcl